Clinical trial
Vascular Effects of Carvedilol Versus Metoprolol in Hypertensive Patients With…
NCT00123604 · St. Paul Heart Clinic, Other · Completed
Key facts
| NCT number | NCT00123604 |
|---|---|
| Title | Vascular Effects of Carvedilol Versus Metoprolol in Hypertensive Patients With Type 2 Diabetes |
| Official title | Effects of Carvedilol and Metoprolol on Endothelial Function in Hypertensive Patients With Type 2 Diabetes Mellitus |
| Lead sponsor | St. Paul Heart Clinic, Other |
| Collaborators | GlaxoSmithKline Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Hypertension, Type 2 Diabetes Mellitus |
| Intervention type | Drug |
| Interventions | Carvedilol, Metoprolol |
| Enrollment | 36 |
| Start date | Jun 1, 2004 |
| Primary completion | Jun 1, 2006 |
| Completion | Jun 1, 2006 |
| First posted | Jul 25, 2005 |
| Last update posted | Nov 18, 2014 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: